Asperger Syndrome Market Research Report - Forecast to 2027

Asperger Syndrome Market Research Report: By Diagnosis (DSM-IV, Differential Diagnosis, GADS, KADI, Childhood Asperger Syndrome Test), by Treatment (Speech-Language Therapy, Occupational Therapy, Medication), and by End-User - Forecast Till 2027

ID: MRFR/Pharma/4383-HCR | February 2021 | Region: Global | 100 pages

Asperger Syndrome Market


The Asperger syndrome market is projected to grow at 6% CAGR during the forecast period of 2017–2023. Asperger’s syndrome is also called Autistic Spectrum Disorder which generally initiates in childhood and continues to stay till death. There are few key differences between those diagnosed with autism and those with Asperger’s syndrome. Several medical professionals have believed that Asperger’s syndrome is a milder form of autism. Generally, the symptoms showed up in the Asperger’s syndrome are milder; however, the children are later diagnosed with an autism spectrum disorder. 


The increasing prevalence of the autism and wide spectrum of the condition are the primary reasons for the overall growth of the Asperger syndrome industry. Recently, World Health Organization has stated that there were around 1 in 160 children diagnosed with autism. Recent studies show that there are several causes for the syndrome such as premature delivery, a child born within a year after its sibling, family history, older parents, any mental disorder, epilepsy, or tumor in the brain. An increasing number of causes for the condition and environmental factors have increased the overall Asperger syndrome market growth in recent years.


COVID 19 Analysis:


The outburst of COVID 19 has significantly increased the rate of mental disorders in several countries. The prolonged lockdown, disturbance in the normalcy of lifestyle, fear of getting ill and economic decline are the primary causes for the psychological disorders. Especially, young adults and children who already possess Asperger syndrome suffer due to the complex changes in their lifestyle. Such individuals were projected to follow a restricted routine within a closed room, restriction in movements has increased the anxiety, stress, and confusion in such individuals. These factors have significantly impacted the growth of the Asperger Syndrome Market value.


Asperger Syndrome Market Dynamics:


Drivers:


The advancements in Psychopharmacology in terms of designing their medications to target specific patients and possessing fewer side effects yet more effective have increased the overall growth of the Asperger Syndrome industry in recent years.


The increasing prevalence of autism spectrum disorder and Asperger syndrome, while there are still many cases that are not given the required medication is creating a significant impact on the growth of the Asperger syndrome market in recent years. 


Market opportunities:


The increasing cases of Asperger syndrome are primarily due to the genetic history and delivering twins or triplets children possessing the condition. If any one of the children possesses the condition, then there are about 95% chances for the other children to have the syndrome. 


The varied availability of therapies and treatments has been utilized in the medical departments to help the children diagnosed with the condition. Some of the most prevalent therapies and medications are dietary changes, medications, psychological therapy, speech and language therapy, art and music therapy, physical and occupational therapy that helps to build the motor skills in the patients. Effective medications like mood stabilizers and seizure control medications like Lamotrigine, Carbatrol, Tegretol, Epitol are helping the medical practitioners to attain their goal in medical cases.


Market restraints:


The symptoms observed in two different patients can be extremely different, and the treatment given to the patients are generally trial and error method which is time-consuming and prevalence of varied perspective of the patients over their symptoms can be extremely different too. Such factors have restricted the growth of the Asperger syndrome market.


The presence of fewer drugs like Aripiprazole and risperidone for managing the symptoms, fewer drugs that are approved by the FDA is considered as the major restraining factor for the growth of the Asperger Syndrome industry.


Asperger Syndrome Market Challenges:


Minimal awareness about the condition is considered as the primary restraint for the growth of the Asperger syndrome industry. Moreover, poor health insurance coverage for treating the symptoms of Asperger Syndrome is restraining the market growth.


The diagnosis and treatment for Asperger Syndrome Disorder require skilled professionals and could be very time-consuming. Effective coordination and deep analysis are required in prescribing the treatment plan for the patient. Poor economic condition is also becoming the primary challenge in the Asperger Syndrome industry.


Asperger Syndrome Market Cumulative growth analysis:


The advancements in the therapies to treat Asperger syndrome have been creating a huge impact on the Asperger syndrome industry in recent years. The advent of gene therapy which involves injecting a health gene onto a harmless virus and then injecting the virus into the patient’s body helps the cells to acquire the protein that is missing. This practice is approved for certain conditions and treatments like vision impairment and a certain type of cancer. Despite the decline in the economy, the market seems to be going steadily with the advancements in technology.


Recently, gene therapy is considered the most effective treatment for Asperger’s syndrome, as the injected genes are capable of reaching the brain cells effectively. The recent experimental treatment on replacing the fragile X syndrome has eased out or even reversed the condition effectively. The abnormal motor activity and anxiety problems were reversed. Other treatments that involve modifying the DNA and RNA in terms of their protein-making instructions, disabling their functionality have been working well. Such advancements in the treatments and medications have impacted the growth of the Asperger Syndrome industry positively. 


Asperger Syndrome Market Value chain analysis:


The Asperger syndrome can be developed into Autism for some children, which involves difficulties in socializing, communication issues, behavior, anxiety, fear, and similar other emotional issues. The condition may persist till adulthood and could bring in difficulties in marriage, as the patient might it difficult to understand the emotions of the partner, lack of humor sense or capability in understanding the other mate’s emotions might affect the quality of life. In the previous years, people have not been aware of the complexity of the condition, but in recent times, the condition is hugely addressed at its early stages. Therefore the complexities of the condition are reduced well ahead of time. The continuous researches based on the condition and treatment or the condition has been increasing in recent years. Some evidence has shown that proper medications such as prenatal vitamins given to expecting mothers have reduced the probability of the child getting the syndrome. 


Asperger Syndrome Market Segment Overview:


Based on Type:



  • Asperger Syndrome

  • Pervasive Developmental Disorder

  • Autistic Disorder

  • Disintegrative Disorder


Based on Deployment:



  • Communication and Behavioral Therapies

  • Applied Behavior Analysis (ABA)

  • Speech and Language Therapy

  • Occupation Therapy


Based on Treatment:



  • Drug Therapies

  • Antipsychotic Drugs

  • SSRIs

  • Stimulants

  • Sleep Medication


Asperger Syndrome Market Regional Analysis:


America is currently in the dominating position in the Asperger Syndrome industry. Over 3.5 million Americans are living with the condition according to a recent study. Within a decade, some regions in America showcases over a 119.4% increase in terms of the number of cases. The costs incurred in treating the condition have increased by over USD 236-262 billion in recent years. Such factors have increased the overall growth of the Asperger Syndrome industry.


The governmental initiatives and presence of leading market players in Europe are the primary reasons for the growth of the Asperger Syndrome industry in Europe. Ease in the reimbursement policies and advancing infrastructure of the healthcare centers are bolstering the growth of the Asperger Syndrome industry. 


Asperger Syndrome Market Competitive Landscape:



  • Eli Lilly and company

  • Shire

  • Jazz Pharmaceuticals

  • Pfizer

  • GlaxoSmithKline

  • Forest laboratories

  • Johnson & Johnson

  • Bristol-Myers Squibb

  • Otsuka pharmaceutical

  • AstraZeneca


Recent developments:


The advent of gene therapy in the Asperger syndrome industry has created tremendous growth in recent years. The modification of a defective gene or changing the characterization of the gene in the patient with the help of a harmless virus carrying a healthy gene is a very effective way of treating the condition. The FDA approval for the gene therapy in treating the Asperger syndrome is bolstering the growth of the Asperger syndrome market value.


The QBM-001 drug which helps in treating the minimal verbal disorder is considered a supreme invention in treating autism and Asperger syndrome. The RNA biomarkers combined with PMVA is utilized to accelerate the efficacy of QBM-001 is another clinical development that has received huge appreciation in the industry.


Asperger Syndrome Market Report Overview:


This report has covered:



  • Market overview

  • COVID 19 Analysis

  • Market dynamics

  • Cumulative growth analysis

  • Value chain analysis

  • Segment overview

  • Regional analysis

  • Competitive landscape

  • Recent developments



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   6.0% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Diagnosis, Treatment, and End-use
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Eli Lilly and Company's, Shire, Jazz Pharmaceuticals, Pfizer, GlaxoSmithKline, Forest Laboratories, Inc., Johnson and Johnson, Bristol-Myers Squibb, Otsuka Pharmaceutical Company, Ltd., Johnson & Johnson Services, Inc., AstraZeneca, Allergan, Inc., and others
  Key Market Opportunities

  • Growing awareness of autistic spectrum disorder
  • Increasing patient pool
  • Unmet medical needs, enhancing regulatory framework
  • Increasing government assistance
  • Rising funding and reimbursement
  •   Key Market Drivers

  • Increasing technological advancements
  • Government-sponsored awareness programs for autism
  • Increasing prevalence of autism and related complications


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Asperger syndrome is a developmental disorder characterized by repetitive behaviors, unusual preoccupations or rituals, limited range of interests, problems with social skills, communication difficulties, and coordination problems.

    Asperger Syndrome Market is expected to exhibit a strong 6% CAGR over the forecast period from 2020 to 2027.

    Growing awareness about autism spectrum disorders is the major driver for the Asperger Syndrome Market.

    Americas dominate the Global Asperger Syndrome Market due to growing awareness about developmental disorders in the region.

    Leading players in the Asperger Syndrome Market include Eli Lilly, Bristol-Myers Squibb, and Shire, among others.

    Table of Contents:

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Asperger Syndrome Market, by Diagnosis

    6.1 Introduction

    6.2 DSM-IV

    6.2.1 Market Estimates & Forecast, 2020–2027

    6.3 Differential Diagnosis

    6.3.1 Market Estimates & Forecast, 2020–2027

    6.4 Childhood Asperger Syndrome Test

    6.4.1 Market Estimates & Forecast, 2020–2027

    6.5 Gilliam Asperger's Disorder Scale (GADS)

    6.5.1 Market Estimates & Forecast, 2020–2027

    6.6 Krug Asperger's Disorder Index (KADI)

    6.6.1 Market Estimates & Forecast, 2020–2027

    6.7 Others

    6.7.1 Market Estimates & Forecast, 2020–2027

    Chapter 7. Global Asperger Syndrome Market, by treatment

    7.1 Introduction

    7.2 Parent Education & Training

    7.2.1 Market Estimates & Forecast, 2020–2027

    7.3 Social Skills Training

    7.3.1 Market Estimates & Forecast, 2020–2027

    7.4 Speech-Language Therapy

    7.4.1 Market Estimates & Forecast, 2020–2027

    7.5 Applied Behavioral Analysis (ABA)

    7.5.1 Market Estimates & Forecast, 2020–2027

    7.6 Medication

    7.6.1 Market Estimates & Forecast, 2020–2027

    Chapter 8. Global Asperger Syndrome Market, by End-User

    8.1 Introduction

    8.2 Hospitals

    8.2.1 Market Estimates & Forecast, 2020–2027

    8.3 Clinics

    8.3.1 Market Estimates & Forecast, 2020–2027

    8.4 Diagnostic Centers

    8.4.1 Market Estimates & Forecast, 2020–2027

    8.5 Drug Stores

    8.5.1 Market Estimates & Forecast, 2020–2027

    8.6 Pharmacies

    8.6.1 Market Estimates & Forecast, 2020–2027

    8.7 Others

    8.7.1 Market Estimates & Forecast, 2020–2027

    Chapter 9. Global Asperger Syndrome Market, by Region

    9.1 Introduction

    9.2 Americas

    9.2.1 North America

    9.2.1.1 U.S.

    9.2.1.1 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 U.K.

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic of Korea

    9.4.6 Rest of Asia Pacific

    9.5 The Middle East & Africa

    9.5.1 United Arab Emirates

    9.5.2 Saudi Arabia

    9.5.3 Oman

    9.5.4 Kuwait

    9.5.5 Qatar

    9.5.6 Rest of the Middle East & Africa

    Chapter 10 Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    10.3.1 Key Developments

    Chapter 11 Company Profiles

    11.1 Eli Lilly and Company’s

    11.1.1 Company Overview

    11.1.2 Types Overview

    11.1.3 Financials

    11.1.4 SWOT Analysis

    11.2 Shire

    11.2.1 Company Overview

    11.2.2 Types Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 Jazz Pharmaceuticals

    11.3.1 Company Overview

    11.3.2 Types Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Pfizer

    11.4.1 Company Overview

    11.4.2 Types/Business Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 GlaxoSmithKline

    11.5.1 Company Overview

    11.5.2 Types Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.6 Forest Laboratories, Inc.

    11.6.1 Company Overview

    11.6.2 Types Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.7 JOHNSON & JOHNSON SERVICES, INC.

    11.7.1 Overview

    11.7.2 Types Overview

    11.7.3 Financials

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Others

    Chapter 12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View Point

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Prediction of Asperger Syndrome industry

    Chapter 13 Appendix

    LIST OF TABLES

    Table 1 Asperger Syndrome Industry Synopsis, 2020–2027

    Table 2 Asperger Syndrome Market Estimates & Forecast, 2020–2027, (USD Million)

    Table 3 Asperger Syndrome Market, by Region, 2020–2027, (USD Million)

    Table 4 Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

    Table 5 Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

    Table 6 Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

    Table 7 North America Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

    Table 8 North America Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

    Table 9 North America Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

    Table 10 U.S. Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

    Table 11 U.S. Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

    Table 12 U.S. Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

    Table 13 Canada Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

    Table 14 Canada Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

    Table 15 Canada Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

    Table 16 South America Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

    Table 17 South America Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

    Table 18 South America Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

    Table 19 Europe Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

    Table 20 Europe Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

    Table 21 Europe Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

    Table 22 Western Europe Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

    Table 23 Western Europe Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

    Table 24 Western Europe Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

    Table 25 Eastern Europe Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

    Table 26 Eastern Europe Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

    Table 27 Eastern Europe Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

    Table 28 Asia Pacific Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

    Table 29 Asia Pacific Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

    Table 30 Asia Pacific Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

    Table 31 The Middle East & Africa Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

    Table 32 The Middle East & Africa Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

    Table 33 The Middle East & Africa Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for the Asperger Syndrome Market

    Figure 3 Segmentation Market Dynamics for the Asperger Syndrome Market

    Figure 4 Global Asperger Syndrome Market Share, by Diagnosis, 2020

    Figure 5 Global Asperger Syndrome Market Share, by Treatment, 2020

    Figure 6 Global Asperger Syndrome Market Share, by End-User, 2020

    Figure 7 Global Asperger Syndrome Market Share, by Region, 2020

    Figure 8 North America Asperger Syndrome Market Share, by Country, 2020

    Figure 9 Europe Asperger Syndrome Market Share, by Country, 2020

    Figure 10 Asia Pacific Asperger Syndrome Market Share, by Country, 2020

    Figure 11 Middle East & Africa Asperger Syndrome Market Share, by Country, 2020

    Figure 12 Global Asperger Syndrome Market: Company Share Analysis, 2020 (%)

    Figure 13 Eli Lilly and Company’s: Key Financials

    Figure 14 Eli Lilly and Company’s: Segmental Revenue

    Figure 15 Eli Lilly and Company’s: Geographical Revenue

    Figure 16 Shire: Key Financials

    Figure 17 Shire: Segmental Revenue

    Figure 18 Shire: Geographical Revenue

    Figure 19 Jazz Pharmaceuticals: Key Financials

    Figure 20 Jazz Pharmaceuticals: Segmental Revenue

    Figure 21 Jazz Pharmaceuticals: Geographical Revenue

    Figure 22 Pfizer: Key Financials

    Figure 23 Pfizer: Segmental Revenue

    Figure 24 Pfizer: Geographical Revenue

    Figure 25 GLAXOSMITHKLINE: Key Financials

    Figure 26 GLAXOSMITHKLINE: Segmental Revenue

    Figure 27 GlaxoSmithKline Geographical Revenue

    Figure 28 Forest Laboratories, Inc.: Key Financials

    Figure 29 Forest Laboratories, Inc.: Segmental Revenue

    Figure 30 Forest Laboratories, Inc.: Geographical Revenue

    Figure 31 JOHNSON & JOHNSON SERVICES, INC.: Key Financials

    Figure 32 JOHNSON & JOHNSON SERVICES, INC.: Segmental Revenue

    Figure 33 JOHNSON & JOHNSON SERVICES, INC.: Geographical Revenue